Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-16

Clinical Trial Update: Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pain management regimens using gabapentin, methadone, and oxycodone with or without venlafaxine in patients with cutaneous squamous cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)
  • Methadone (methadone)
  • Oxycodone (oxycodone)
  • Venlafaxine hydrochloride (Venlafaxine hydrochloride)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8, Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 | Phase 2 | Status: COMPLETED | Results posted: 2026-04-16